- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Bladder Cancer in United States
Total 24618 results
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBladder Cancer | Urethral CancerUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedBladder Cancer | Urethral CancerUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingBladder Cancer | Non-Muscle-Invasive Urothelial CarcinomaUnited States
-
University of BirminghamUnknownBladder CancerUnited Kingdom
-
Institute of Cancer Research, United KingdomUnknown
-
M.D. Anderson Cancer CenterActive, not recruitingMalignant Solid Neoplasm | Metastatic Lung Non-Small Cell Carcinoma | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Metastatic Melanoma | Stage III Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Unresectable Melanoma | Clinical Stage III Cutaneous... and other conditionsUnited States
-
Rush University Medical CenterWithdrawnImmunotherapy | Cancer of Skin | Exercise, Aerobic | Cancer of Kidney | Cancer of BladderUnited States
-
TengionCompletedBladder DiseaseUnited States
-
Dana-Farber Cancer InstituteSiemens Medical SolutionsRecruitingKidney Cancer | Urologic Neoplasms | Prostate Cancer | Bladder Cancer | Urethral Cancer | Penile Cancer | Urologic Cancer | Testicular CancerUnited States
-
University of California, IrvineTerminatedCarcinoma, Transitional CellUnited States
-
UroGen Pharma Ltd.RecruitingBladder Cancer | Non-muscle Invasive Bladder Cancer | Urothelial Carcinoma Bladder | NMIBC | Urothelial Carcinoma Recurrent | Carcinoma in Situ of BladderUnited States, Italy, Spain
-
ImmunityBio, Inc.RecruitingNon-muscle Invasive Bladder CancerUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)CompletedKidney Cancer | Breast Cancer | Colorectal Cancer | Pancreatic Cancer | Lung Cancer | Bladder CancerUnited States
-
Spectrum Pharmaceuticals, IncAllerganTerminatedBladder CancerUnited States, Canada
-
University of ChicagoNational Cancer Institute (NCI)CompletedBladder Cancer | Drug/Agent Toxicity by Tissue/OrganUnited States
-
Uro-1 MedicalRecruiting
-
Adlai Nortye Biopharma Co., Ltd.Merck Sharp & Dohme LLCActive, not recruitingCervical Cancer | Triple-negative Breast Cancer | NSCLC, Squamous or Non-Squamous | Urothelial Carcinoma of the Bladder | Microsatellite Stable (MSS) Colorectal Cancer (CRC)United States, France
-
Merck Sharp & Dohme LLCRecruitingBladder CancerCanada, France, Italy, Netherlands, Turkey, Brazil, Spain, United States, Finland, Puerto Rico, Singapore
-
Mount Vernon Cancer Centre at Mount Vernon HospitalCompletedBladder CancerUnited Kingdom
-
Merck Sharp & Dohme LLCRecruitingHigh-risk Non-muscle Invasive Bladder CancerCanada, Belgium, United States, Australia, Austria, France, Germany, Greece, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Peru, Poland, Portugal, Spain, Switzerland, Turkey, United Kingdom, China, Brazil, Colombia, ... and more
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterUnited States
-
National Cancer Institute (NCI)CompletedBreast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Lung Cancer | Bladder CancerUnited States
-
ImmunityBio, Inc.Active, not recruiting
-
Acrotech Biopharma Inc.CompletedCarcinoma, Transitional Cell | Bladder Cancer | Bladder NeoplasmSpain, France, Belgium, United States, Argentina, Croatia
-
Royal Devon and Exeter NHS Foundation TrustKing's College Hospital NHS Trust; Portsmouth Hospitals NHS Trust; North Bristol... and other collaboratorsRecruitingBladder Cancer | Bladder Outflow ObstructionUnited Kingdom
-
Spectrum Pharmaceuticals, IncCompletedBladder CancerCanada, United States, Poland
-
BioNTech US Inc.Bristol-Myers SquibbCompletedMelanoma | Carcinoma, Non-Small-Cell Lung | Lung Cancer | Urinary Bladder Cancer | Skin Cancer | Transitional Cell Carcinoma of the Bladder | Malignant Melanoma | Bladder TumorsUnited States
-
Loyola UniversityAstellas Pharma IncCompletedOveractive Bladder SyndromeUnited States
-
AstraZenecaActive, not recruitingMuscle Invasive Bladder CancerUnited States, Belgium, France, Germany, Italy, Spain, United Kingdom, Canada, Poland, Taiwan, Vietnam, Turkey, Korea, Republic of, Brazil, Czechia, Japan, Philippines, Israel, Chile, Australia, Netherlands, Russian Federation
-
UroSee CorporationUnknownBladder TumorUnited States
-
Northwestern UniversityNorthShore University HealthSystemCompletedKidney Cancer | Prostate Cancer | Bladder CancerUnited States
-
Deepak KilariGenentech, Inc.; Medical College of Wisconsin; ExelixisRecruitingBladder CancerUnited States
-
M.D. Anderson Cancer CenterRecruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Advanced Malignant Solid Neoplasm | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Clinical Stage III Cutaneous Melanoma AJCC v8 and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterNovartis PharmaceuticalsCompletedBladder Cancer | Ureter Cancer | Renal Pelvis CancerUnited States
-
National Cancer Institute (NCI)Active, not recruitingStage III Bladder Cancer AJCC v8 | Bladder Urothelial CarcinomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Bladder Urothelial Carcinoma | Metastatic Renal Pelvis Urothelial Carcinoma | Metastatic Ureter Urothelial Carcinoma | Metastatic Urethral Urothelial Carcinoma | Recurrent Bladder Urothelial Carcinoma | Recurrent Renal Pelvis Urothelial Carcinoma | Recurrent Ureter Urothelial Carcinoma and other conditionsUnited States
-
Astellas Pharma Global Development, Inc.Seagen Inc.RecruitingCarcinoma in Situ | Urinary Bladder Neoplasms | Non-muscle Invasive Bladder Cancer | Carcinoma Transitional Cell | NMIBCUnited States, Canada, France, Spain, United Kingdom, Germany
-
Queen Mary University of LondonGlaxoSmithKlineUnknownBladder CancerUnited Kingdom
-
Hoffmann-La RocheRecruitingMuscle-invasive Bladder CancerBelgium, Korea, Republic of, Japan, Brazil, China, United States, Singapore, France, United Kingdom, Canada, Greece, Italy, Spain, Turkey, Russian Federation, Ukraine, Israel, Czechia, Colombia, Hong Kong, Argentina, Germany, Ireland, Polan... and more
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingUrinary Bladder Neoplasms | Muscle-Invasive Bladder CancerRussian Federation, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia, Finland, France, Germany, Greece, Israel, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Norway, Portugal, Roman... and more
-
AstraZenecaCompletedPancreatic Ductal Adenocarcinoma | Triple-negative Breast Cancer | Urothelial Bladder CancerUnited States, Belgium, Korea, Republic of, Poland, Netherlands
-
Matthew GalskyBristol-Myers Squibb; Icahn School of Medicine at Mount SinaiCompleted
-
National Cancer Institute (NCI)TerminatedMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Regional Transitional Cell Cancer of the Renal Pelvis and Ureter | Transitional Cell Carcinoma of the Bladder | Localized Transitional Cell Cancer of the...United States
-
AstraZenecaRecruitingMuscle Invasive Bladder CancerNetherlands, United Kingdom, Korea, Republic of, Canada, Germany, Italy, Poland, Spain, Turkey, Vietnam, Argentina, Japan, France, Brazil, Taiwan, United States, Israel, Austria, Chile, Colombia, Greece, Hong Kong, Mexico, Portugal, Russian... and more
-
National Cancer Institute (NCI)Active, not recruitingMalignant Solid Neoplasm | Renal Cell Carcinoma | Clear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Sarcomatoid Renal Cell Carcinoma | Stage III Bladder Cancer AJCC v8 | Stage III Renal Pelvis Cancer AJCC v8 | Stage III Ureter Cancer AJCC v8 | Stage... and other conditionsUnited States
-
The Methodist Hospital Research InstituteCollaborating for the Advancement of Interdisciplinary Research in Benign...RecruitingOveractive Bladder | Lower Urinary Tract Symptoms | Neurogenic Bladder | Neurogenic Detrusor Overactivity | Neuro: Neurogenic BladderUnited States
-
University of California, DavisRecruitingOveractive Bladder Syndrome | Neuropathic BladderUnited States
-
University of OklahomaCompletedRefractory Overactive BladderUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedBladder CancerUnited States, Canada